FBXO17 and central nervous system cancer: The risk score for each glioma was determined as follows: 0.772546974482237 * the expression levels of IGF2BP3 + (-0.529440079138294) * the expression levels of RDM1 + 0.959791181375875 * the expression levels of NSUN7 + 1.28748170838841 * the expression levels of EXO1 + (−0.92777652353892) * the expression levels of APOBEC3F + 0.746260894529048 * the expression levels of FBXO17 + (−0.545584467299167) * FAM46A + 0.999495382483528 * the expression levels of ANG + 0.682420092015883 * the expression levels of ADARB2 + (−0.565975323034877) * the expression levels of EIF4E1B.